Specific Substances: No Specific Substances or Agents are Selected for this Nomination
Nomination Date: 02/17/2010
Nominator: Private Individual
Rationale: Concern regarding safety of DHASCO® [Registration symbol] and ARASCO® [Registration symbol], microbial derived oils containing long-chain polyunsaturated fatty acid triaclglycerols used to supplement infant formulas. Concern that consumption may adversely affect nutrient absorption, cholesterol and lipid metabolism, oxidative damage leading to neurodegenerative and other diseases.
NTP Principles: not specified